Modelling Lung Disease in Vitro/Vivo 2019
DOI: 10.1136/thorax-2019-btsabstracts2019.96
|View full text |Cite
|
Sign up to set email alerts
|

S90 A novel organotypic model of bronchial dysplasia for preclinical screening of potential therapeutic agents for early squamous lung cancer (SQC)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 1 publication
0
1
0
Order By: Relevance
“…For example, the reproduction of a genetic lesion (CDKN2A disruption) in vitro was shown to induce dysregulation in SOX2 production in the HBEC ALI model. This provided sufficient predictive validity to human bronchial dysplasia to enable preclinical screens of novel agents to treat squamous lung cancer (Porter et al, 2019).…”
Section: D Air-liquid Interface Respiratory Epithelium Modelsmentioning
confidence: 99%
“…For example, the reproduction of a genetic lesion (CDKN2A disruption) in vitro was shown to induce dysregulation in SOX2 production in the HBEC ALI model. This provided sufficient predictive validity to human bronchial dysplasia to enable preclinical screens of novel agents to treat squamous lung cancer (Porter et al, 2019).…”
Section: D Air-liquid Interface Respiratory Epithelium Modelsmentioning
confidence: 99%